ArticleClinical epigenetics2019

SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.